tiprankstipranks
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Smart Value
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

EBS Stock Latest News

Emergent Biosolutions: Strategic Share Repurchase and Diversified Revenue Streams Signal Strong Buy Opportunity
RatingsEmergent Biosolutions: Strategic Share Repurchase and Diversified Revenue Streams Signal Strong Buy Opportunity
21h ago
EBS
Emergent BioSolutions rises 11.8%
PremiumThe Fly
Emergent BioSolutions rises 11.8%
2d ago
EBS
Emergent BioSolutions rises 9.0%
PremiumThe Fly
Emergent BioSolutions rises 9.0%
2d ago
EBS
Emergent BioSolutions announces $50M stock repurchase program
PremiumThe Fly
Emergent BioSolutions announces $50M stock repurchase program
2d ago
EBS
Emergent Biosolutions’ Strategic Investments and Divestitures Justify Buy Rating
PremiumRatings
Emergent Biosolutions’ Strategic Investments and Divestitures Justify Buy Rating
12d ago
EBS
Hikma Pharmaceuticals announces Health Canada approval of KLOXXADO nasal spray
PremiumThe FlyHikma Pharmaceuticals announces Health Canada approval of KLOXXADO nasal spray
13d ago
EBS
Emergent BioSolutions announces $27M in incremental sales
Premium
The Fly
Emergent BioSolutions announces $27M in incremental sales
15d ago
EBS
Emergent BioSolutions reinforces commitment to expanding access to NARCAN
Premium
The Fly
Emergent BioSolutions reinforces commitment to expanding access to NARCAN
20d ago
EBS
Emergent BioSolutions, Rocketvax announce investment agreement
PremiumThe Fly
Emergent BioSolutions, Rocketvax announce investment agreement
21d ago
EBS
Emergent BioSolutions Sells Baltimore Facility to Syngene
PremiumCompany Announcements
Emergent BioSolutions Sells Baltimore Facility to Syngene
22d ago
8K
EBS
Emergent BioSolutions to sell Baltimore-Bayview facility for $36.5M
PremiumThe Fly
Emergent BioSolutions to sell Baltimore-Bayview facility for $36.5M
23d ago
EBS
Emergent BioSolutions’ Earnings Call: Balancing Achievements and Challenges
PremiumCompany Announcements
Emergent BioSolutions’ Earnings Call: Balancing Achievements and Challenges
28d ago
EBS
Target reports Q4 beat, Walgreens reportedly near go-private deal: Morning Buzz
PremiumThe FlyTarget reports Q4 beat, Walgreens reportedly near go-private deal: Morning Buzz
29d ago
LH
BBY
Emergent BioSolutions falls -24.6%
Premium
The Fly
Emergent BioSolutions falls -24.6%
29d ago
EBS
Emergent BioSolutions falls -16.0%
Premium
The Fly
Emergent BioSolutions falls -16.0%
29d ago
EBS
Positive Outlook for Emergent Biosolutions: Buy Rating Supported by Strong Contract Wins and Financial Recovery
PremiumRatings
Positive Outlook for Emergent Biosolutions: Buy Rating Supported by Strong Contract Wins and Financial Recovery
29d ago
EBS
Emergent BioSolutions Reports Strong 2024 Financial Turnaround
PremiumCompany Announcements
Emergent BioSolutions Reports Strong 2024 Financial Turnaround
29d ago
EBS
Closing Bell Movers: Okta spikes 15% on earnings beat and outlook
PremiumThe Fly
Closing Bell Movers: Okta spikes 15% on earnings beat and outlook
29d ago
GO
DSP
Emergent BioSolutions Reports 2024 Financial Results
PremiumCompany Announcements
Emergent BioSolutions Reports 2024 Financial Results
29d ago
8K
EBS
Emergent BioSolutions sees Q1 revenue $200M-$240M, consensus $279M
PremiumThe FlyEmergent BioSolutions sees Q1 revenue $200M-$240M, consensus $279M
29d ago
EBS
Emergent BioSolutions reports Q4 adjusted EPS 5c, consensus (50c)
Premium
The Fly
Emergent BioSolutions reports Q4 adjusted EPS 5c, consensus (50c)
29d ago
EBS
Emergent BioSolutions sees FY25 revenue $750M-$850M, consensus $1.13B
Premium
The Fly
Emergent BioSolutions sees FY25 revenue $750M-$850M, consensus $1.13B
29d ago
EBS

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >